ÂÜÀòÂÒÂ×

Jonathan Rowell has extensive experience in pharmacovigilance and regulatory compliance, currently serving as Senior Director and Head of Pharmacovigilance QA at Johnson & Johnson since November 2022. Prior to this role, Jonathan held various leadership positions at The Janssen Pharmaceutical Companies of Johnson & Johnson from July 2016 to January 2020, including Director of Bioresearch Regulatory Compliance and Director of Pharmacovigilance Audit Strategy. Jonathan's career began at Britannia Pharmaceuticals Limited as Medical Services Manager, followed by a role as Senior Pharmacovigilance Inspector at the MHRA from April 2009 to January 2015. Jonathan holds a Master of Science in Pharmacovigilance from the University of Hertfordshire and a Bachelor of Science in Genetics from the University of Leicester.